Article Versions Notes

Rehman HM, Sajjad M, Ali MA, Gul R, Irfan M, Naveed M, Bhinder MA, Ghani MU, Hussain N, Said ASA, et al. Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches. Vaccines. 2023; 11(1):131. https://doi.org/10.3390/vaccines11010131

Rehman, Hafiz Muzzammel, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Irfan, Muhammad Naveed, Munir Ahmad Bhinder, Muhammad Usman Ghani, Nadia Hussain, Amira S. A. Said, and et al. 2023. "Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches" Vaccines 11, no. 1: 131. https://doi.org/10.3390/vaccines11010131

Rehman, H. M., Sajjad, M., Ali, M. A., Gul, R., Irfan, M., Naveed, M., Bhinder, M. A., Ghani, M. U., Hussain, N., Said, A. S. A., Al Haddad, A. H. I., & Saleem, M. (2023). Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches. Vaccines, 11(1), 131. https://doi.org/10.3390/vaccines11010131